The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 621, Issue 1-2, 2007, Pages 61-74

  Yang, Zhen ^a   Harrison, Corey M ^a   Chuang, Gin C ^a   Ballinger, Scott W ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cardiovascular disease; Mitochondria; mtDNA; Tobacco smoke

Indexed keywords

TOBACCO SMOKE;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ENERGY; CELL FUNCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; SMOKING; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MITOCHONDRIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 34447266863     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.02.010     Document Type: Article

References (126)

1. World Health Organization, The world health report 2003 - shaping the future: Neglected Global Epidemics, World Health Organization, Geneva, Switzerland, 2003, pp. 83-102.
2. American Heart Association, Heart Disease and Stroke Statistics - 2005 Update, American Heart Association, Dallas, TX, 2005, pp. 1a-60.
3. American Heart, and Association. Heart disease and stroke statistics - 2006 update. Circulation 105 (2006) 1-67
4. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126 Review
5. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91 (2003) 7A-11A
6. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 29-38
7. Puddu G.M., Cravero E., Arnone G., Muscari A., and Puddu P. Molecular aspects of atherogenesis: new insights and unsolved questions. J. Biomed. Sci. 12 (2005) 839-853
8. Ceconi C., Boraso A., Cargnoni A., and Ferrari R. Oxidative stress in cardiovascular disease: myth or fact?. Arch. Biochem. Biophys. 420 (2003) 217-221
9. Diaz M.N., Frei B., Vita J.A., and Keaney J.F. Mechanisms of disease - antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337 (1997) 408-416
10. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases - the role of oxidant stress. Circ. Res. 87 (2000) 840-844
11. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18 (2000) 655-673
12. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 36 (2001) S41-S44
13. Reilly M., Delanty N., Lawson J.A., and Fitzgerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
14. 2 isoprostanes in hypercholesterolemia. Circulation 98 (1998) 2822-2828
15. Pratico D., Tangirala R.K., Rader D.J., Rokach J., and FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE deficient mice. Nat. Med. 4 (1998) 1189-1192
16. 2α-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3449-3454
17. Ito H., Torii M., and Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin. Exp. Hypertens. 17 (1995) 803-816
18. Holland J.A., Ziegler L.M., and Meyer J.W. Atherogenic levels of low-density lipoprotein increase hydrogen peroxide generation in cultured human endothelial cells: possible mechanism of heightened endocytosis. J. Cell. Physiol. 166 (1996) 144-151
19. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91 (1993) 2546-2551
20. Watts G.F., and Playford D.A. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in a non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 141 (1998) 17-30
21. Rousselot D.B., Bastard J.P., and Jaudon M.C. Consequences of the diabetic status on the oxidant/antioxidant balance. Diab. Metab. 26 (2000) 163-176
22. Ruiz-Pesini E., Mishmar D., Brandon M., Procaccio V., and Wallace D.C. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303 (2004) 223-226
23. Wallace D.C. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354 (2005) 169-180
24. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev Genet. 39 (2005) 359-407
25. Zhang Y., Marcillat O., Giulivi C., Ernster L., and Davies K.J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265 (1990) 16330-16336
26. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552 (2003) 335-344
27. Forman H.J., and Boveris A. In: Prior W.A. (Ed). Free Radicals in Biology (1982), Academic Press, Orlando 65-90
28. Forman H.J., and Boveris A. Superoxide radical and hydrogen peroxide in mitochondria. In: Prior W.A. (Ed). Free Radicals in Biology (1982), Academic Press, Orlando 65-90
29. Boveris A., and Turrens J.F. Production of superoxide anion by the NADH dehydrogenase of mammalian mitochondria. In: Bannister J., and Hill H. (Eds). Chemical and Biochemical Aspects of Superoxide and Superoxide Dismutase (1980), Elsevier, Amsterdam 84-91
30. Turrens J.F., and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191 (1980) 421-427
31. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
32. - in vascular smooth muscle cells. Circ. Res. 77 (1995) 29-36
33. Chen K., Vita J.A., Berk B.C., and Keaney Jr. J.F. c-Jun-N-terminal kinase activation by hydrogen peroxide in endothelial cells involves Src-dependent epidermal growth factor receptor transactivation. J. Biol. Chem. 276 (2001) 16045-16050
34. 2. J. Biol. Chem. 271 (1996) 4138-4142
35. Kim S.M., Byun J.S., Jung Y.D., et al. The effects of oxygen radicals on the activity of nitric oxide synthase and guanylate cyclase. Exp. Mol. Med. 30 (1998) 221-226
36. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
37. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., Utsumi H., Machida Y., Egashira K., and Takeshita A. Direct evidence for increased hydroxyl radicals orginating from superoxide in the failing myocardium. Circ. Res. 86 (2000) 152-157
38. Kissner R., Nauser T., Bugnon P., Lye P.G., and Loppenol W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem. Res. Toxicol. 10 (1997) 1285-1292
39. Ballinger S.W., Patterson W.C., Yan C.-N., Doan R., Burow D.L., Young C.G., Yakes F.M., Van Houten B., Ballinger C.A., Freeman B.A., and Runge M.S. Hydrogen peroxide and peroxynitrite induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ. Res. 86 (2000) 960-966
40. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
41. MacMillan-Crow L.A., Crow J.P., and Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical gyrosine residues. Biochemistry 37 (1998) 1613-1622
42. Levonen A.L., Patel R.P., Brookes P., Go Y.M., Jo H., Parthasarathy S., Anderson P.G., and Darley-Usmar V.M. Mechanisms of cell signaling by nitric oxide and peroxynitrite: from mitochondria to MAP kinases. Antioxid Redox Signal. 3 (2001) 215-229 Review
43. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356 (1998) 1-11
44. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9 (1996) 836-844
45. Kimura S., Zhang G.X., Nishiyama A., Shokoji T., Yao L., Fan Y.Y., Rahman M., Suzuki T., Maeta H., and Abe Y. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45 (2005) 860-866
46. Ramachandran A., Levonen A.L., Brookes P.S., Ceaser E., Shiva S., Barone M.C., and Darley-Usmar V.M. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic. Biol. Med. 33 (2002) 1465-1474
47. Ramachandran A., Moellering D.R., Ceaser E., Shiva S., Xu J., and Darley-Usmar V.M. Inhibition of mitochondrial protein synthesis results in increased endothelial cell susceptibility to nitric oxide-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6643-6648
48. Cassina A., and Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328 (1996) 309-316
49. Ramachandran A., Ceaser E., and Darley-Usmar V.M. Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 384-389
50. Garlid K.D., Jaburek M., and Jezek P. Mechanism of uncoupling proteins action. Biochem. Soc. Trans. 29 (2001) 803-806
51. Jaburek M., Varecha M., Gimeno R.E., Dembski M., Jezek P., Zhang M., Burn P., Tartaglia L.A., and Garlid K.D. Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J. Biol. Chem. 274 (1999) 26003-26007
52. + transport and regulation. Biochem. Soc. Trans. 29 (2001) 806-811
53. Nedergaard J., Golozoubova V., Matthias A., Shabalina I., Ohba K., Ohlson K., Jacobsson A., and Cannon B. Life without UCP1: mitochondrial, cellular, and organismal characteristics of the UCP1-ablated mice. Biochem. Soc. Trans. 29 (2001) 756-763
54. Stuart J.A., Cadenas S., Jacobsons M.B., Roussel D., and Brand M.D. Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim. Biophys. Acta 1504 (2001) 144-158
55. Dulloo A.G., Samec S., and Seydoux J. Uncoupling protein 3 and fatty acid metabolism. Biochem. Soc. Trans. 29 (2001) 785-791
56. Nedergaard J., and Cannon B. The "novel" "uncoupling" proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions. Exp. Physiol. 88 (2003) 65-84
57. Talbot D.A., Lambert A.J., and Brand M.D. Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3. FEBS Lett. 556 (2004) 111-115
58. Manna S.K. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 273 (1998) 13245-13254
59. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267 (1992) 5317-5323
60. Maehara K., Oh-Hashi K., and Isobe K.-I. Early growth-responsive-1-dependent manganese superoxide dismutase gene transcription mediated by platelet-derived growth factor. FASEB J. 15 (2001) 2025-2026
61. Yan L.-J., and Sohal R.S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 12896-12901
62. Yakes F.M., Van B., and Houten. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 514-519
63. Duan J., and Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity in two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can. J. Physiol. Pharmacol. 67 (1989) 704-709
64. Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., and Wallace D.C. Maternally trasnmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet. 1 (1992) 11-15
65. Ballinger S.W., Van Houten B., Jin G.F., Conklin C.A., and Godley B.F. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exper. Eye Res. 68 (1999) 765-772
66. Yan L.-J., and Sohal R.S. Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damage to specific mitochondrial proteins. Free Radic. Biol. Med. 29 (2000) 1143-1150
67. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., and Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11853-11858
68. Flohe L., and Otting F. Superoxide dismutase assays. Methods Enzymol. 105 (1984) 93-104
69. Hausladen A., and Fridovich I. Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol. 269 (1996) 37-41
70. Tarpey M.M., Wink D., and Grisham M. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R431-R444
71. Castro L., Eiserich J.P., Sweeney S., Radi R., and Freeman B.A. Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration. Arch. Biochem. Biophys. 421 (2004) 99-107
72. Knight-Lozano C.A., Young C.G., Burow D.L., Hu Z., Uyeminami D., Pinkerton K., Ischiropoulos H., and Ballinger S.W. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105 (2002) 849-854
73. Cassina A.M., Hodara R., Souza J.M., Thomson L., Castro L., Ischiropoulos H., Freeman B.A., and Radi R. Cytochrome c nitration by peroxynitrite. J. Biol. Chem. 275 (2000) 21409-21415
74. Chen Y.-R., Deterding L.J., Sturgeon B.E., Tomer K.B., and Mason R.P. Protein oxidation of cytochrome c by reactive halogen species enhances its peroxidase activity. J. Biol. Chem. 277 (2002) 29781-29791
75. Brookes P.S., Zhang J., Dai L., Zhou F., Parks D.A., Darley-Usmar V.M., Anderson P.G., Brookes P.S., Zhang J., Dai L., Zhou F., Parks D.A., Darley-Usmar V.M., and Anderson P.G. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J. Mol. Cell Cardiol. 33 (2001) 69-82
76. Schulze-Osthoff K., Los M., and Baeuerle P.A. Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50 (1995) 735-741
77. Devary Y., Rosette C., DiDonato J.A., and Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261 (1993) 1442-1445
78. Mohan N., and Meltz M.M. Induction of nuclear factor κB after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Rad. Res. 140 (1994) 97-104
79. Schulze-Osthoff K., Beyaert R., Vandervoorde V., Haegeman G., and Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12 (1993) 3095-3104
80. Chen K., Thomas S.R., Albano A., Murphy M.P., and Keaney J.F. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J. Biol. Chem. (2004)
81. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R.M., Hunter G., McIntyre K., and Runge M.S. Mitochondrial integrity and function in atherogenesis. Circulation 106 (2002) 544-549
82. Li M., Absher M., Liang P., Russell J.C., Sobel B.E., and Fukagawa N.K. High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells. Exp. Biol. Med. 226 (2001) 450-457
83. Yao P.M., and Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J. Biol. Chem. 276 (2001) 42468-42476
84. Asmis R., and Begley J.G. Oxidized LDL promotes peroxide mediated mitochondrial dysfunction and cell death in human macrophages. Circ. Res. 92 (2003) e20-e29
85. van Jaarsveld H., Kuyl J.M., and Alberts D.W. Exposure of rats to low concentrations of cigarette smoke increases myocardial sensitivity to ischaemia/reperfusion. Basic Res. Cardiol. 87 (1992) 393-399
86. Gvozdjakova A., Bada V., Sany L., Kucharska J., Kruty F., Bozek P., Trstanski L., and Gvozdjak J. Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria. Cardiovasc. Res. 18 (1984) 229-232
87. Corral-Debrinski M., Shoffner J.M., Lott M.T., and Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275 (1992) 169-180
88. Corral-Debrinski M., Stepien G., Shoffner J.M., Lott M.T., Kanter K., and Wallace D.C. Hypoxemia is associated with mitochondrial DNA damage and gene induction: implications for cardiac disease. JAMA 266 (1991) 1812-1816
89. Aliev G., Seyidova D., Neal M.L., Shi J., Lamb B.T., Siedlak S.L., Vinters H.V., Head E., Perry G., Lamanna J.C., Friedland R.P., and Cotman C. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann. N.Y. Acad. Sci. 977 (2002) 45-64
90. Ide T., Tsutsui H., Hayashidani S., Kang D., Suematsu N., Nakamura K., Utsumi H., Hamasaki N., and Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88 (2001) 529-535
91. Chen Z., Siu B., Ho Y.-S., Vincent R., Chua C.C., Hamdy R.C., and Chua B.H.L. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell Cardiol. 30 (1998) 2281-2289
92. Asimakis G., Lick S., and Patterson W. Postischemic recovery of contractile function is impaired in SOD2 (+/-) but not SOD1 (+/-) mouse hearts. Circulation 105 (2002) 981-986
93. Blanc J., Alves-Guerra M.C., Esposito B., Rousset S., Gourdy P., Ricquier D., Tedgui A., Miroux B., and Mallat Z. Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107 (2003) 388-390
94. Teshima Y., Akao M., Jones S.P., and Marban E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ. Res. 93 (2003) 192-200
95. Bienengraeber M., Ozcan C., and Terzic A. Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. J. Mol. Cell Cardiol. 35 (2003) 861-865
96. Bernal-Mizrachi C., Gates A.C., Weng S., Imamura T., Knutsen R.H., Desantis P., Coleman T., Townsend R.R., Muglia L.J., and Semenkovich C.F. Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature 435 (2005) 502-506
97. Bernal-Mizrachi C., Weng S., Li B., Nolte L.A., Feng C., Coleman T., Holloszy J.O., and Semenkovich C.F. Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 961-968
98. Yang H., Roberts L.J., Shi M.J., Zhou L.C., Ballard B.R., Richardson A., and Guo Z.M. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ. Res. 95 (2004) 1075-1081
99. Yang Z., Knight C.A., Mamerow M., Vickers K., Penn A., Postlethwait E., and Ballinger S.W. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apoE-/- mice fed a chow diet. Circulation 110 (2004) 3715-3720
100. Gvozdjak J., Gvozdjakova A., Kucharska J., and Bada V. The effect of smoking on myocardial metabolism. Czech. Med. 10 (1987) 47-53
101. Gvozdjakova A., Kucharska J., and Gvozdjak J. Effect of smoking on the oxidative processes of cardiomyocytes. Cardiology 1992 (1992) 81-84
102. van Jaarsveld H., Kuyl J.M., and Alberts D.W. Antioxidant vitamin supplementation of smoke exposed rats partially protects against myocardial ischemic/reperfusion injury. Free Radic. Res. Commun. 17 (1992) 263-269
103. Davis J., Shelton L., Watnabe I., and Arnold J. Passive smoking affects endothelium and platelets. Arch. Intern. Med. 149 (1989) 386-389
104. 10 level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardiomyopathy. BioFactors 10 (1999) 61-65
105. Penn A., Chen L.C., and Synder C.A. Inhalation of steady-state sidestream smoke from one cigarette promotes atherosclerotic plaque development. Circulation 90 (1994) 1363-1367
106. Vayssier-Taussat M., Camilli T., Aron Y., Meplan C., Hainaut P., Polla B.S., and Weksler B. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H1293-H1300
107. Lu K.P., Alejandro N.F., Taylor K.M., Joyce M.M., Spencer T.E., and Ramos K.S. Differential expression of ribosomal L31, Zis, gas-5 and mitochondrial mRNAs following oxidant induction of proliferative vascular smooth muscle cell phenotypes. Atherosclerosis 160 (2002) 273-280
108. St Clair D.K., Jordan J.A., Wan X.S., and Gairola C.G. Protective role of manganese superoxide dismutase against cigarette smoke-induced cytotoxicity. J. Toxicol. Environ. Health 43 (1994) 239-249
109. Li S.X., Chen W., Srinivasan S.R., and Berenson G.S. Childhood blood pressure as a predictor of arterial stiffness in young adults - the Bogalusa Heart Study. Hypertension 43 (2004) 541-546
110. McGill H., McMahan C.A., Herderick E., Tracy R.E., Malcom G.T., Zieske A.W., Strong J.P., and the PDAY Research Group. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 836-845
111. Asmussen I., and Kjeldsen K. Intimal ultrastructure of human umbilical arteries. Circ. Res. 36 (1975) 579-589
112. Raitakari O., Juonala M., Kahonen M., Taittonen L., Maki-Torkko N., Jarvisalo M., Uhari M., Jokeinen E., Ronnemaa T., Akerblom H., and Viikari J. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The cardiovascular risk in young Finns study. JAMA 290 (2003) 2277-2283
113. Matturri L., Ottaviani G., and Lavezzi A. Early atherosclerotic lesions in infancy: role of parental cigarette smoking. Virchows Archiv. 447 (2005) 74-80
114. Hutchison S.J., Glantz S.A., Zhu B.Q., Sun Y.P., Chou T.M., Chatterjee K., Deedwania P.C., Parmley W.W., and Sudhir K. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J. Am. Coll. Cardiol. 32 (1998) 1463-1467
115. Michael J.R., Markewitz B.A., and Kohan D.E. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am. J. Physiol. 273 (1997) L768-74-L-774
116. Zhu B.Q., Sun Y.P., Sudhir K., Sievers R.E., Browne A.E.M., Gao L.R., Hutchison S.J., Chou T.M., Deedwania P.C., Chatterjee K., Glantz S.A., and Parmley W.W. Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period. J. Am. Coll. Cardiol. 30 (1997) 1878-1885
117. Berrahmoune H., Lamont J., Herbeth B., FitzGerald P., and Visvikis-Siest S. Biological determinants of an reference vaules for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin. Chem. 52 (2006) 504-510
118. Bouhours-Nouet N., May-Panloup P., Coutant R., de Casson F.B., Descamps P., Douay O., Reynier P., Ritz P., Malthiery Y., and Simard G. Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta. Am. J. Physiol.-Endocrinol. Metab. 288 (2005) E171-E177
119. 32P-Postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Cancer Res. 46 (1986) 3046-3054
120. Bandy B., and Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 8 (1990) 523-539
121. Couch N.P. On the arterial consequences of smoking. J. Vasc. Surg. 3 (1986) 807-812
122. Napoli C., De Nigris F., Welch J.S., Calara F.B., Stuart R.O., Glass C.K., and Palinski W. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 105 (2002) 1360-1367
123. Chen J.Q., and Yager J.D. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis. Ann. N.Y. Acad. Sci. 1028 (2004) 258-272
124. Chen J.Q., Eshete M., Alworth W.L., and Yager J.D. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J. Cell Biochem. 93 (2004) 358-373
125. Chen J.Q., Delannoy M., Cooke C., and Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E1011-E1022
126. Felty Q., and Roy D. Mitochondrial signals to nucleus regulate estrogen-induced cell growth. Med. Hypotheses 64 (2005) 133-141